Chronic lymphocytic leukemia often arises by a multiclonal selection process
Por:
Bagnara, D, Mazzarello, AN, Cardente, N, Vergani, S, Kasar, S, Fernandes, S, Ferrer, G, Ghiotto, F, Barrientos, JC, Kolitz, JE, Rai, KR, Allen, SL, Colombo, M, Fais, F, Brown, JR, Ferrarini, M and Chiorazzi, N
Publicada:
1 ago 2025
Ahead of Print:
20 feb 2025
Resumen:
Although chronic lymphocytic leukemia (CLL) is diagnosed by identifying a circulating B-cell clone that exceeds 5x103/mu L, additional distinct clones (ADC) have been identified in various studies. Notably, the numbers of ADC documented in these studies has increased as the various technologies evolved. To better define the frequency and the characteristics of ADC in CLL, we used a next-generation sequencing platform that affords high sequencing depth along with steps that limit over-counting to analyze IGHV-IGHD-IGHJ gene rearrangements in circulating CD5+ B cells from 57 patients. Notably, all patients had at least one ADC, in addition to the clinically relevant clone. In 46 patients for whom lymphocyte count data were available, 44 had at least one ADC above the threshold of 1 B cell/mu L and, remarkably, the average number of ADC was 12 per patient. Notably, in two patients, the predominant ADC qualified clinically as a separate CLL clone and in the remaining cases as low/high-count monoclonal B-cell lymphocytosis clones. Moreover, in 11 patients studied longitudinally, predominant ADC were persistent and often increased in number. ADC in patients with CLL exhibited 4-fold more stereotyped IGHV-IGHD-IGH rearrangements than found in CD5+ B cells from healthy individuals, and IGHV use, somatic mutations, and Ig isotype distribution were similar between predominant ADC and clinically relevant clones. Thus, finding multiple expanded clones within the CD5+ B cells is the rule in patients with CLL, indicating that leukemogenesis is a multiclonal process that likely involves competition among B cells with special B-cell receptor features.
Filiaciones:
Bagnara, D:
Univ Genoa, Dept Expt Med, Genoa, Italy
Northwell Hlth, Feinstein Inst Med Res, Karches Ctr Oncol Res, Manhasset, NY 11030 USA
Mazzarello, AN:
Univ Genoa, Dept Expt Med, Genoa, Italy
Northwell Hlth, Feinstein Inst Med Res, Karches Ctr Oncol Res, Manhasset, NY 11030 USA
Cardente, N:
Univ Genoa, Dept Expt Med, Genoa, Italy
Vergani, S:
Northwell Hlth, Feinstein Inst Med Res, Karches Ctr Oncol Res, Manhasset, NY 11030 USA
Miltenyi Botec BV & Co KG, Bergisch Gladbach, Germany
Kasar, S:
Dana Farber Canc Inst, CLL Ctr, Boston, MA USA
Harvard Med Sch, Boston, MA USA
Takeda Pharmaceut, Cambridge, MA USA
Fernandes, S:
Dana Farber Canc Inst, CLL Ctr, Boston, MA USA
Harvard Med Sch, Boston, MA USA
:
Northwell Hlth, Feinstein Inst Med Res, Karches Ctr Oncol Res, Manhasset, NY 11030 USA
Josep Carreras Leukaemia Res Inst IJC, Badalona, Spain
Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain
Ghiotto, F:
Univ Genoa, Dept Expt Med, Genoa, Italy
IRCCS Osped Policlin San Martino, Genoa, Italy
Barrientos, JC:
Northwell Hlth, Feinstein Inst Med Res, Karches Ctr Oncol Res, Manhasset, NY 11030 USA
Zucker Sch Med Hofstra Northwell, Dept Mol Med, Hempstead, NY USA
Zucker Sch Med Hofstra Northwell, Dept Med, Hempstead, NY USA
Kolitz, JE:
Northwell Hlth, Feinstein Inst Med Res, Karches Ctr Oncol Res, Manhasset, NY 11030 USA
Zucker Sch Med Hofstra Northwell, Dept Mol Med, Hempstead, NY USA
Zucker Sch Med Hofstra Northwell, Dept Med, Hempstead, NY USA
Rai, KR:
Northwell Hlth, Feinstein Inst Med Res, Karches Ctr Oncol Res, Manhasset, NY 11030 USA
Zucker Sch Med Hofstra Northwell, Dept Mol Med, Hempstead, NY USA
Zucker Sch Med Hofstra Northwell, Dept Med, Hempstead, NY USA
Allen, SL:
Northwell Hlth, Feinstein Inst Med Res, Karches Ctr Oncol Res, Manhasset, NY 11030 USA
Zucker Sch Med Hofstra Northwell, Dept Mol Med, Hempstead, NY USA
Zucker Sch Med Hofstra Northwell, Dept Med, Hempstead, NY USA
Colombo, M:
IRCCS Osped Policlin San Martino, Genoa, Italy
Fais, F:
Univ Genoa, Dept Expt Med, Genoa, Italy
IRCCS Osped Policlin San Martino, Genoa, Italy
Brown, JR:
Dana Farber Canc Inst, CLL Ctr, Boston, MA USA
Harvard Med Sch, Boston, MA USA
Ferrarini, M:
Univ Genoa, Dept Expt Med, Genoa, Italy
Chiorazzi, N:
Northwell Hlth, Feinstein Inst Med Res, Karches Ctr Oncol Res, Manhasset, NY 11030 USA
Zucker Sch Med Hofstra Northwell, Dept Mol Med, Hempstead, NY USA
Zucker Sch Med Hofstra Northwell, Dept Med, Hempstead, NY USA
Green Submitted, gold
|